| 3N59 |  | Type II dehydroquinase from Mycobacterium Tuberculosis complexed with 3-dehydroshikimate |
| 3N8K |  | Type II dehydroquinase from Mycobacterium tuberculosis complexed with citrazinic acid |
| 3KVI |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA thioesterase FlK - T42A mutant in complex with fluoro-acetate |
| 3KVU |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA FlK - T42S mutant in complex with Acetyl-CoA |
| 3KVZ |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA thiesterase FlK - wild type FlK in complex with FAcCPan |
| 3KW1 |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA FlK - Wild type FlK in complex with FAcOPan |
| 3KX8 |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA thioesterase FlK |
| 3KUV |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA thioesterase FlK - T42S mutant in complex with acetate. |
| 3KUW |  | Structural basis of the activity ans substrate specificity of the fluoroacetyl-CoA thioesterase FlK - T42S mutant in complex with Fluoro-acetate |
| 3KV7 |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA thioesterase FlK - wild type FlK in complex with acetate |
| 3KV8 |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA thioesterase FlK - Wild type FlK in complex with fluoro-acetate |
| 3KX7 |  | Structural basis of the activity and substrate specificity of the fluoroacetyl-CoA FlK - apo wild type FlK |
| 3LE8 |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 1.70 Angstrom resolution in complex with 2-(2-((benzofuran-2-carboxamido)methyl)-5-methoxy-1H-indol-1-yl)acetic acid |
| 2WVI |  | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF BUBR1 |
| 3HWO |  | Crystal structure of Escherichia coli enterobactin-specific isochorismate synthase EntC in complex with isochorismate |
| 3KGV |  | Crystal Structure of Human DNA-dependent Protein Kinase Catalytic Subunit (DNA-PKcs) |
| 3ISJ |  | Crystal structure of pantothenate synthetase from Mycobacterium tuberculosis in complex with 5-methoxy-N-(methylsulfonyl)-1H-indole-2-carboxamide |
| 3IMC |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 1.6 Ang resolution in complex with fragment compound 5-methoxyindole, sulfate and glycerol |
| 3IME |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 2.40 Ang resolution in complex with fragment compound 1-Benzofuran-2-carboxylic acid |
| 3IMG |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 1.8 Ang resolution in a ternary complex with fragment compounds 5-methoxyindole and 1-benzofuran-2-carboxylic acid |
| 3IUB |  | Crystal structure of pantothenate synthetase from Mycobacterium tuberculosis in complex with 5-Methoxy-N-(5-methylpyridin-2-ylsulfonyl)-1H-indole-2-carboxamide |
| 3IUE |  | Crystal structure of pantothenate synthetase in complex with 2-(5-methoxy-2-(5-Methylpyridin-2-ylsulfonylcarbamoyl)-1H-indol-1-yl) acetic acid |
| 3IVC |  | Crystal structure of pantothenate synthetase in complex with 2-(2-((benzofuran-2-ylmethoxy)carbonyl)-5-methoxy-1H-indol-1-yl)acetic acid |
| 3IVG |  | Crystal structure of pantothenate synthetase in complex with 2-(2-((benzofuran-2-sulfonamido)methyl)-5-methoxy-1H-indol-1-yl)acetic acid |
| 3IVX |  | Crystal structure of pantothenate synthetase in complex with 2-(2-(benzofuran-2-ylsulfonylcarbamoyl)-5-methoxy-1H-indol-1-yl)acetic acid |
| 3G04 |  | Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody |
| 3H4I |  | Chimeric Glycosyltransferase for the generation of novel natural products |
| 3H4T |  | Chimeric Glycosyltransferase for the generation of novel natural products - GtfAH1 in complex with UDP-2F-Glc |
| 3ESL |  | Crystal structure of the conserved N-terminal domain of the mitotic checkpoint component BUB1 |
| 2K5X |  | Chemical shift structure of COLICIN E9 DNASE domain with its cognate immunity protein IM9 |
| 3COV |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 1.5 Ang resolution- apo form |
| 3COW |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 1.8 Ang resolution- in complex with sulphonamide inhibitor 2 |
| 3COY |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 2.05 Ang resolution- in complex with sulphonamide inhibitor 3 |
| 3COZ |  | Crystal Structure of Mycobacterium Tuberculosis Pantothenate Synthetase at 2.0 Ang resolution- in complex with sulphonamide inhibitor 4 |
| 3E4R |  | Crystal structure of the alkanesulfonate binding protein (SsuA) from the phytopathogenic bacteria Xanthomonas axonopodis pv. citri bound to HEPES |
| 3DAR |  | Crystal structure of D2 domain from human FGFR2 |
| 2QM4 |  | Crystal structure of human XLF/Cernunnos, a non-homologous end-joining factor |
| 2PZJ |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmF in complex with NAD+ |
| 2PZK |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmG in complex with NAD |
| 2PZL |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmG in complex with NAD and UDP |
| 2PZM |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmG in complex with NAD and UDP |
| 2Q1S |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmF in complex with NADH |
| 2Q1T |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmF in complex with NAD+ and UDP |
| 2Q1U |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmF in complex with NAD+ and UDP |
| 2Q1W |  | Crystal structure of the Bordetella bronchiseptica enzyme WbmH in complex with NAD+ |
| 2OFP |  | Crystal structure of Escherichia coli ketopantoate reductase in a ternary complex with NADP+ and pantoate |
| 2J66 |  | STRUCTURAL CHARACTERISATION OF BTRK DECARBOXYLASE FROM BUTIROSIN BIOSYNTHESIS |
| 2C7T |  | CRYSTAL STRUCTURE OF THE PLP-BOUND FORM OF BTRR, A DUAL FUNCTIONAL AMINOTRANSFERASE INVOLVED IN BUTIROSIN BIOSYNTHESIS. |
| 2C81 |  | CRYSTAL STRUCTURES OF THE PLP- AND PMP-BOUND FORMS OF BTRR, A DUAL FUNCTIONAL AMINOTRANSFERASE INVOLVED IN BUTIROSIN BIOSYNTHESIS. |
| 2HE0 |  | Crystal structure of a human Notch1 ankyrin domain mutant |
| 1YON |  | Escherichia coli ketopantoate reductase in complex with 2-monophosphoadenosine-5'-diphosphate |
| 1XES |  | Crystal structure of stilbene synthase from Pinus sylvestris |
| 1XET |  | Crystal structure of stilbene synthase from Pinus sylvestris, complexed with methylmalonyl CoA |
| 2FN0 |  | Crystal structure of Yersinia enterocolitica salicylate synthase (Irp9) |
| 2FN1 |  | Crystal structures of Yersinia enterocolitica salicylate synthase (Irp9) in complex with the reaction products salicylate and pyruvate |
| 1Z56 |  | Co-Crystal Structure of Lif1p-Lig4p |
| 2ASU |  | Crystal Structure of the beta-chain of HGFl/MSP |
| 1TJ6 |  | Crystal structure of the Xenopus tropicalis Spred1 EVH-1 domain |
| 1YYH |  | Crystal structure of the human Notch 1 ankyrin domain |
| 1YJQ |  | Crystal structure of ketopantoate reductase in complex with NADP+ |
| 1XOD |  | Crystal structure of X. tropicalis Spred1 EVH-1 domain |
| 2BF9 |  | ANISOTROPIC REFINEMENT OF AVIAN (TURKEY) PANCREATIC POLYPEPTIDE AT 0.99 ANGSTROMS RESOLUTION. |
| 1RQF |  | Structure of CK2 beta subunit crystallized in the presence of a p21WAF1 peptide |
| 1PWA |  | Crystal structure of Fibroblast Growth Factor 19 |
| 1PPY |  | Native precursor of pyruvoyl dependent Aspartate decarboxylase |
| 1PQE |  | S25A mutant of pyruvoyl dependent aspartate decarboxylase |
| 1PQF |  | Glycine 24 to Serine mutation of aspartate decarboxylase |
| 1PQH |  | Serine 25 to Threonine mutation of aspartate decarboxylase |
| 1PYQ |  | Unprocessed Aspartate Decarboxylase Mutant, with Alanine inserted at position 24 |
| 1PYU |  | Processed Aspartate Decarboxylase Mutant with Ser25 mutated to Cys |
| 1PT0 |  | Unprocessed Pyruvoyl Dependent Aspartate Decarboxylase with an Alanine insertion at position 26 |
| 1PT1 |  | Unprocessed Pyruvoyl Dependent Aspartate Decarboxylase with Histidine 11 Mutated to Alanine |
| 1URF |  | HR1B DOMAIN FROM PRK1 |
| 1PZN |  | Rad51 (RadA) |
| 1M3U |  | Crystal Structure of Ketopantoate Hydroxymethyltransferase complexed the Product Ketopantoate |
| 1QIA |  | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN |
| 1QIC |  | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN |
| 1N0W |  | Crystal structure of a RAD51-BRCA2 BRC repeat complex |
| 1KS9 |  | Ketopantoate Reductase from Escherichia coli |
| 1IK9 |  | CRYSTAL STRUCTURE OF A XRCC4-DNA LIGASE IV COMPLEX |
| 1GP9 |  | A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING |
| 1K9Y |  | The PAPase Hal2p complexed with magnesium ions and reaction products: AMP and inorganic phosphate |
| 1K9Z |  | The PAPase Hal2p complexed with zinc ions |
| 1KA0 |  | The PAPase Hal2p complexed with a sodium ion and the reaction product AMP |
| 1KA1 |  | The PAPase Hal2p complexed with calcium and magnesium ions and reaction substrate: PAP |
| 1GMN |  | CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR |
| 1GMO |  | CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR |
| 1JP4 |  | Crystal Structure of an Enzyme Displaying both Inositol-Polyphosphate 1-Phosphatase and 3'-Phosphoadenosine-5'-Phosphate Phosphatase Activities |
| 1IHO |  | CRYSTAL APO-STRUCTURE OF PANTOTHENATE SYNTHETASE FROM E. COLI |
| 1E0O |  | CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX |
| 1QGX |  | X-RAY STRUCTURE OF YEAST HAL2P |
| 1QIB |  | CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN |
| 1CIZ |  | X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY |
| 1B8Y |  | X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY |
| 1CAQ |  | X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY |
| 1BLX |  | P19INK4D/CDK6 COMPLEX |
| 1JOH |  | THE STRUCTURE OF ANTIAMOEBIN I, A MEMBRANE-ACTIVE PEPTIDE |
| 1NK1 |  | NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION |
| 1SGF |  | CRYSTAL STRUCTURE OF 7S NGF: A COMPLEX OF NERVE GROWTH FACTOR WITH FOUR BINDING PROTEINS (SERINE PROTEINASES) |
| 1AW8 |  | PYRUVOYL DEPENDENT ASPARTATE DECARBOXYLASE |
| 2JXR |  | STRUCTURE OF YEAST PROTEINASE A |
| 1CZI |  | CHYMOSIN COMPLEX WITH THE INHIBITOR CP-113972 |
| 1EPO |  | DIRECT OBSERVATION BY X-RAY ANALYSIS OF THE TETRAHEDRAL ""INTERMEDIATE"" OF ASPARTIC PROTEINASES |
| 1BET |  | NEW PROTEIN FOLD REVEALED BY A 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF NERVE GROWTH FACTOR |
| 1SAC |  | THE STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID P COMPONENT |
| 1BBS |  | X-RAY ANALYSES OF PEPTIDE INHIBITOR COMPLEXES DEFINE THE STRUCTURAL BASIS OF SPECIFICITY FOR HUMAN AND MOUSE RENINS |
| 1EED |  | X-RAY CRYSTALLOGRAPHIC ANALYSIS OF INHIBITION OF ENDOTHIAPEPSIN BY CYCLOHEXYL RENIN INHIBITORS |
| 1ENT |  | X-RAY ANALYSES OF ASPARTIC PROTEINASES. THE THREE-DIMENSIONAL STRUCTURE AT 2.1 ANGSTROMS RESOLUTION OF ENDOTHIAPEPSIN |
| 1SMR |  | THE 3-D STRUCTURE OF MOUSE SUBMAXILLARY RENIN COMPLEXED WITH A DECAPEPTIDE INHIBITOR CH-66 BASED ON THE 4-16 FRAGMENT OF RAT ANGIOTENSINOGEN |
| 1MPP |  | X-RAY ANALYSES OF ASPARTIC PROTEINASES. V. STRUCTURE AND REFINEMENT AT 2.0 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM MUCOR PUSILLUS |
| 1PDA |  | STRUCTURE OF PORPHOBILINOGEN DEAMINASE REVEALS A FLEXIBLE MULTIDOMAIN POLYMERASE WITH A SINGLE CATALYTIC SITE |
| 2BB2 |  | X-RAY ANALYSIS OF BETA B2-CRYSTALLIN AND EVOLUTION OF OLIGOMERIC LENS PROTEINS |
| 4GCR |  | STRUCTURE OF THE BOVINE EYE LENS PROTEIN GAMMA-B (GAMMA-II)-CRYSTALLIN AT 1.47 ANGSTROMS |
| 4CMS |  | X-RAY ANALYSES OF ASPARTIC PROTEINASES IV. STRUCTURE AND REFINEMENT AT 2.2 ANGSTROMS RESOLUTION OF BOVINE CHYMOSIN |
| 3ER5 |  | THE ACTIVE SITE OF ASPARTIC PROTEINASES |
| 4ER4 |  | HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES |
| 5ER2 |  | HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR. THE ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE RIGID BODY SHIFT IN THE ENZYME |
| 2ER0 |  | X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES |
| 2ER7 |  | X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION |
| 2ER9 |  | X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES. |
| 5ER1 |  | A rational approach to the design of antihypertensives. x-ray studies of complexes between ASPARTIC PROTEINASES and AMINOALCOHOL RENIN INHIBITORS |
| 5PEP |  | X-RAY ANALYSES OF ASPARTIC PROTEASES. II. THREE-DIMENSIONAL STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF PORCINE PEPSIN AT 2.3 ANGSTROMS RESOLUTION |
| 4INS |  | THE STRUCTURE OF 2ZN PIG INSULIN CRYSTALS AT 1.5 ANGSTROMS RESOLUTION |
| 1XY1 |  | CRYSTAL STRUCTURE ANALYSIS OF DEAMINO-OXYTOCIN. CONFORMATIONAL FLEXIBILITY AND RECEPTOR BINDING |
| 1XY2 |  | CRYSTAL STRUCTURE ANALYSIS OF DEAMINO-OXYTOCIN. CONFORMATIONAL FLEXIBILITY AND RECEPTOR BINDING |
| 1PPT |  | X-RAY ANALYSIS (1.4-ANGSTROMS RESOLUTION) OF AVIAN PANCREATIC POLYPEPTIDE. SMALL GLOBULAR PROTEIN HORMONE |
